TWiV 716: COVID-19 clinical update #48 with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #48, Daniel Griffin reviews effect of spike amino acid changes on neutralization with monoclonal antibodies, Sputnik V safety and efficacy results, increased reactogenicity after a single vaccine dose in seropositive individuals, single dose vaccination in seropositive health care workers, and results of three clinical trials on the use of anticoagulants.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Resistance of variants to mAb neutralization (bioRxiv)
- Safety and efficacy of Sputnik V (Lancet)
- Increased vaccine reactogenicity in seropositives (medRxiv)
- Single dose vaccination in seropositive health care workers (medRxiv)
- Update on vaccine intervals (CDC)
- Single dose AZD1222 results (Lancet preprints)
- Three RCT on anticoagulants (NIH)
- Letters read on TWiV 716
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]